Panacea Index Logo

Command Palette

Search for a command to run...

Advanced glycation end products (AGE) and diabetes: cause, effect, or both?

Current diabetes reports
January 1, 2014
Helen Vlassara et al. (2 authors)
Journal ArticleResearch Support, N.I.H., ExtramuralReviewHuman Study
Study Details

Study Goal

The researchers aimed to explore the relationship between exogenous advanced glycation end products (AGEs), chronic inflammation, insulin resistance (IR), and type 2 diabetes (T2D), and evaluate dietary AGE restriction as a nonpharmacologic intervention.

Results Summary

The study found that excessive consumption of AGEs contributes to chronic inflammation, IR, and T2D, and that dietary AGE restriction effectively lowers AGE levels, restores innate defenses, and improves IR.

Population

Not specified (general discussion, likely referencing broader populations with IR or T2D).

Effective Dosage

Not specified.

Duration

Not specified.

Interactions

None mentioned.

Extracted Claims (9)
InterventionDirectionEndpointPopulationDosageImpactClaim #
over-nutrition and obesity
increase
insulin resistance
-
-
associated with
#1
chronically elevated oxidant stress and chronic inflammation
increase
insulin resistance
-
-
results from
#2
excessive consumption of advanced glycation end products with the standard western diet
increase
inflammation
-
-
is a major cause for
#3
advanced glycation end products
increase
islet β-cell injury, peripheral insulin resistance and diabetes
-
-
are increasingly seen as a potential risk for
#4
chronic exogenous oxidant AGE pressure
decrease
innate defense mechanisms
-
-
depletes
#5
depletion of innate defense mechanisms
increase
inflammation, insulin resistance, type 2 diabetes and its complications
-
-
raises susceptibility to
#6
dietary AGE restriction
decrease
AGEs
-
-
effectively lowers
#7
dietary AGE restriction
increase
innate defenses
-
-
restores
#8
dietary AGE restriction
decrease
insulin resistance
-
-
improves
#9
Abstract

Despite new and effective drug therapies, insulin resistance (IR), type 2 diabetes mellitus (T2D) and its complications remain major medical challenges. It is accepted that IR, often associated with over-nutrition and obesity, results from chronically elevated oxidant stress (OS) and chronic inflammation. Less acknowledged is that a major cause for this inflammation is excessive consumption of advanced glycation end products (AGEs) with the standard western diet. AGEs, which were largely thought as oxidative derivatives resulting from diabetic hyperglycemia, are increasingly seen as a potential risk for islet β-cell injury, peripheral IR and diabetes. Here we discuss the relationships between exogenous AGEs, chronic inflammation, IR, and T2D. We propose that under chronic exogenous oxidant AGE pressure the depletion of innate defense mechanisms is an important factor, which raises susceptibility to inflammation, IR, T2D and its complications. Finally we review evidence on dietary AGE restriction as a nonpharmacologic intervention, which effectively lowers AGEs, restores innate defenses and improves IR, thus, offering new perspectives on diabetes etiology and therapy.

Medical Subject Headings (MeSH)
Diabetes Mellitus, Type 2Diabetes, GestationalFemaleGlycation End Products, AdvancedHumansPregnancy
Study Links
Quality Scores
Safety20
Efficacy75/10
Quality80/10
Citation Metrics
Total Citations406
Citations/Year36.9
Relative Citation Ratio15.86
NIH Percentile99.1%
Research Impact Scores
APT Score0.75
Weight Score2.00
Normalized Score0.54